Lalani A-KA, Li H, Heng DY, Wood L, Kalirai A, Bjarnason GA, Sim H-W, Kollmannsberger CK, Kapoor A, Hotte SJ, Vanhuyse M, Czaykowski P, Reaume MN, Soulieres D, Venner P, North S, Basappa NS. First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience. CUAJ [Internet]. 2017 Apr. 11 [cited 2024 Apr. 25];11(3-4):112-7. Available from: https://cuaj.ca/index.php/journal/article/view/4398